Enlivex (ENLV) Non-Current Debt (2018 - 2025)
Enlivex (ENLV) posted Non-Current Debt of $426,000 for Q3 2025, up 1.7% from $419,000 a year earlier and up 97.2% from the prior quarter.
Powered by 
Analysis
Enlivex (ENLV) Non-Current Debt (2018 - 2025) Analysis & Trends
At the end of FY2024, Enlivex's Non-Current Debt came in at $299,000, down 56.4% from FY2023.
- Annual Non-Current Debt has declined for three consecutive years, though with a five-year compound annual growth rate of 0.1% (FY2019 to FY2024).
- In prior years, Enlivex's Non-Current Debt was $686,000 in FY2023 (-83.6%), $4.19 million in FY2022 (-22.2%), $5.39 million in FY2021 (+980.0%) and $499,000 in FY2020 (+67.4%).
- The Q3 2025 figure stands as the highest quarterly Non-Current Debt since Q2 2024.
- On a year-over-year basis, Non-Current Debt increased in 1 of the last eight quarters, with an average decline of 63.9%.
- The strongest year-over-year quarter for Non-Current Debt in the past five years was Q4 2021, with growth of 980.0%; the weakest was Q3 2024, with a decline of 89.0%.
- According to Business Quant data, Non-Current Debt for the three prior quarters was $216,000 (Q2 2025), $264,000 (Q1 2025) and $299,000 (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 37.34 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 62.48 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 51.08 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -108.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 51.86 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 23.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 60.50 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Enlivex | 1.58 Mn | -54.81 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 426,000.00 |
| Jun 30, 2025 | 216,000.00 |
| Mar 31, 2025 | 264,000.00 |
| Dec 31, 2024 | 299,000.00 |
| Sep 30, 2024 | 419,000.00 |
| Jun 30, 2024 | 499,000.00 |
| Mar 31, 2024 | 587,000.00 |
| Dec 31, 2023 | 686,000.00 |
| Sep 30, 2023 | 3.82 Mn |
| Jun 30, 2023 | 3.70 Mn |
| Mar 31, 2023 | 4.00 Mn |
| Dec 31, 2022 | 4.19 Mn |
| Sep 30, 2022 | 4.61 Mn |
| Jun 30, 2022 | 4.64 Mn |
| Mar 31, 2022 | 5.23 Mn |
| Dec 31, 2021 | 5.39 Mn |
| Sep 30, 2021 | 5.35 Mn |
| Jun 30, 2021 | 405,000.00 |
| Mar 31, 2021 | 449,000.00 |
| Dec 31, 2020 | 499,000.00 |
API Access
Enlivex Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=ENLV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "ENLV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=ENLV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();